SMI
11.239,83
PKT
-4,76
PKT
-0,04
%
Werbung
Analysen zu SMI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
11.04.25 | Richemont Buy | UBS AG | |
11.04.25 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
11.04.25 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
11.04.25 | Givaudan Neutral | UBS AG | |
11.04.25 | Givaudan Hold | Deutsche Bank AG | |
11.04.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
11.04.25 | Givaudan Buy | Goldman Sachs Group Inc. | |
10.04.25 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
10.04.25 | Givaudan Underperform | Jefferies & Company Inc. | |
10.04.25 | Zurich Insurance Overweight | Barclays Capital | |
10.04.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
10.04.25 | UBS Buy | Deutsche Bank AG | |
10.04.25 | Swiss Re Overweight | JP Morgan Chase & Co. | |
10.04.25 | Givaudan Add | Baader Bank | |
10.04.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
10.04.25 | Givaudan Underperform | Jefferies & Company Inc. | |
10.04.25 | Novartis Neutral | UBS AG | |
10.04.25 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
09.04.25 | Novartis Neutral | UBS AG | |
09.04.25 | UBS Hold | Jefferies & Company Inc. | |
09.04.25 | Richemont Hold | Deutsche Bank AG | |
08.04.25 | Richemont Overweight | JP Morgan Chase & Co. | |
08.04.25 | Richemont Buy | Jefferies & Company Inc. | |
08.04.25 | UBS Outperform | RBC Capital Markets | |
07.04.25 | Roche Buy | UBS AG | |
07.04.25 | Novartis Buy | Deutsche Bank AG | |
07.04.25 | Givaudan Add | Baader Bank | |
07.04.25 | Roche Sell | Deutsche Bank AG | |
07.04.25 | UBS Overweight | JP Morgan Chase & Co. | |
07.04.25 | Novartis Neutral | JP Morgan Chase & Co. | |
04.04.25 | Novartis Buy | Deutsche Bank AG | |
04.04.25 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
04.04.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
04.04.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
03.04.25 | Roche Sell | Deutsche Bank AG | |
03.04.25 | Richemont Buy | UBS AG | |
03.04.25 | Novartis Buy | Deutsche Bank AG | |
03.04.25 | Novartis Outperform | Bernstein Research | |
03.04.25 | Roche Outperform | Bernstein Research | |
03.04.25 | Givaudan Buy | Goldman Sachs Group Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.